Wednesday, 17 July 2019

India News

  • Cold tolerant gene identified in trout fish

    India |  News | By BioSpectrum Bureau  | 0 Comment | 31 Oct, 2012

    New Delhi: A group of scientists at the directorate of Cold Water Fisheries Research, Bhimtal, led by Dr Ashoktaru Barat, principal scientist, have identified and characterized Glycerol pho...Read more

  • Bilcare to implement drug authentication project

    India |  News | By BioSpectrum Bureau  | 0 Comment | 31 May, 2012

    Mumbai: The Council of Scientific and Industrial Research (CSIR), India, under its New Millennium Indian Technology Leadership Initiative (NMITLI) Scheme, has approved the implementation of...Read more

  • DNDi, Cipla to work on ARV therapy for children

    India |  News | By BioSpectrum Bureau  | 0 Comment | 23 Jul, 2012

    Mumbai: The Drugs for Neglected Diseases initiative (DNDi), a not-for-profit research and development (R&D) organization, has signed a new collaboration with Indian drug manufacturer Ci...Read more

  • FDA continues review of Crofelemer beyond goal date

    India |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 06 Sep, 2012

    Mumbai: The Food and Drug Administration has advised Salix Pharmaceuticals, Mumbai-based Glenmark's collaborative partner, that the new drug application (NDA) for Crofelemer 125 mg tablets ...Read more

  • Biocon clocks revenue worth $121 mn

    India |  News | By BioSpectrum Bureau  | 0 Comment | 30 Jul, 2013

    Bangalore: Indian biopharma giant Biocon reported healthy growth of 22 percent for Q1 FY14. The firm clocked revenues worth $121 million (Rs723 crore), EBITDA of $29.50 million (Rs175 crore...Read more

  • Trivitron JV to lead immunodiagnostics sector in 3 years

    India |  News | By BioSpectrum Bureau  | 0 Comment | 08 Nov, 2012

    Bangalore: Trivitron Healthcare entered in a strategic partnership with Diasorin Group, a global leader in $11 billion immune segment, in order to establish itself in the immunodiagnostic ...Read more

  • Sandoz focuses on developing modern drugs for TB'

    India |  News | By BioSpectrum Bureau  | 0 Comment | 22 Mar, 2012

    Sandoz is the generic drug subsidiary of Novartis, a multinational pharmaceutical company. The company develops, manufactures and markets generic drugs as well as pharmaceutical and biotech...Read more

  • What the UK plans to do at Bangalore India BIO?

    India |  News | By BioSpectrum Bureau  | 0 Comment | 30 Jan, 2014

    A positive business environment, access to global expertise and the presence of world renowned universities, is helping the UK to nurture some of the most innovative companies. Life science...Read more

  • Accuray announces first two CyberKnife systems in India

    India |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Singapore: Accuray, the premier radiation oncology company, announced that Medanta - The Medicity Cancer Institute, and the Roentgen-BLK Super Speciality Hospital both recently acquired an...Read more

  • India's new pharma pricing policy will be a profitability challenge: Glenn Saldanha

    India |  Opinion | By BioSpectrum Bureau  | 0 Comment | 20 May, 2013

    The Indian pharmaceutical industry has witnessed a healthy growth in the last decade, driven by factors like rising consumption levels in the country and strong demand from export markets. ...Read more

  • Asia's challenge: Meeting US, EU requirements

    India |  Opinion | By BioSpectrum Bureau  | 0 Comment | 12 Oct, 2012

    One of the biggest challenges in developing and manufacturing antibodies is proving the equivalence or similarity to the reference product. Antibodies are highly complex molecules with seco...Read more

  • Cipla acquires 51 percent stake in Yemen

    India |  News | By BioSpectrum Bureau  | 0 Comment | 05 Jul, 2014

    Singapore: Given the recent preference to local manufacturing, this secures the company's presence in a fast growing market. Cipla already has a leading position in Yemen with over 200 pro...Read more

  • Asia has potential in NGS research: Dr Partha Majumdar

    India |  Influencers | By BioSpectrum Bureau  | 0 Comment | 02 Aug, 2012

    Dr Partha Majumder is a principal investigator representing India in the International Cancer Genome Consortium, focussing on oral cancer as a part of the ICGC activities, particularly the ...Read more

  • Indian President praises 1Clik diabetes device

    India |  News | By BioSpectrum Bureau  | 0 Comment | 28 Jan, 2013

    Mumbai: The Indian President, Mr Pranab Mukherjee, and the Governor of the Indian state of Tripura, Dr D Y Patil, praised the latest ground breaking diabetes device developed by Rana Arefie...Read more

  • Boehringer heart drug is particularly effective in Asian population

    India |  News | By BioSpectrum Bureau  | 0 Comment | 13 Sep, 2012

    Singapore: Boehringer Ingelheim has reported that in Asian populations, Pradaxa (dabigatran etexilate) offers considerable benefits for the management of patients with atrial fibrillation (...Read more

  • Apollo India to setup proton therapy cancer center

    India |  News | By BioSpectrum Bureau  | 0 Comment | 21 Jan, 2013

    Chennai: Apollo Hospitals will establish a Proton Therapy Center in India, the first of its kind across South East Asia, Africa and Australia. The launch marks the beginning of the next w...Read more

  • Biocon insulin study gives positive results

    India |  Company results | By BioSpectrum Bureau  | 0 Comment | 31 Oct, 2012

    Bangalore: The global phase III study for Biocon's recombinant human insulin (Insugen(R)), in Type 1 diabetes mellitus patients, has demonstrated comparable safety and efficacy with the inn...Read more

  • India to soon decide on FDI policy in pharma

    India |  News | By BioSpectrum Bureau  | 0 Comment | 13 Aug, 2013

    Singapore: Ahead of the raging issue of Foreign Direct Investment (FDI) in the pharmaceutical sector in India, the country's finance minister P chadambaram has said that the government woul...Read more



Survey Box

Is Blockchain offering a solution to the healthcare industry?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls